Literature DB >> 16714391

The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion.

Saber M Hussain1, Amanda K Javorina, Amanda M Schrand, Helen M Duhart, Syed F Ali, John J Schlager.   

Abstract

This investigation was designed to determine whether nano-sized manganese oxide (Mn-40 nm) particles would induce dopamine (DA) depletion in a cultured neuronal phenotype, PC-12 cells, similar to free ionic manganese (Mn(2+)). Cells were exposed to Mn-40 nm, Mn(2+) (acetate), or known cytotoxic silver nanoparticles (Ag-15 nm) for 24 h. Phase-contrast microscopy studies show that Mn-40 nm or Mn(2+) exposure did not greatly change morphology of PC-12 cells. However, Ag-15 nm and AgNO(3) produce cell shrinkage and irregular membrane borders compared to control cells. Further microscopic studies at higher resolution demonstrated that Mn-40 nm nanoparticles and agglomerates were effectively internalized by PC-12 cells. Mitochondrial reduction activity, a sensitive measure of particle and metal cytotoxicity, showed only moderate toxicity for Mn-40 nm compared to similar Ag-15 nm and Mn(2+) doses. Mn-40 nm and Mn(2+) dose dependently depleted DA and its metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), while Ag-15 nm only significantly reduced DA and DOPAC at concentrations of 50 mug/ml. Therefore, the DA depletion of Mn-40 nm was most similar to Mn(2+), which is known to induce concentration-dependent DA depletion. There was a significant increase (> 10-fold) in reactive oxygen species (ROS) with Mn-40 nm exposure, suggesting that increased ROS levels may participate in DA depletion. These results clearly demonstrate that nanoscale manganese can deplete DA, DOPAC, and HVA in a dose-dependent manner. Further study is required to evaluate the specific intracellular distribution of Mn-40 nm nanoparticles, metal dissolution rates in cells and cellular matrices, if DA depletion is induced in vivo, and the propensity of Mn nanoparticles to cross the blood-brain barrier or be selectively uptaken by nasal epithelium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714391     DOI: 10.1093/toxsci/kfl020

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  70 in total

1.  Preparation of cells for assessing ultrastructural localization of nanoparticles with transmission electron microscopy.

Authors:  Amanda M Schrand; John J Schlager; Liming Dai; Saber M Hussain
Journal:  Nat Protoc       Date:  2010-03-25       Impact factor: 13.491

Review 2.  Industrial toxicants and Parkinson's disease.

Authors:  W Michael Caudle; Thomas S Guillot; Carlos R Lazo; Gary W Miller
Journal:  Neurotoxicology       Date:  2012-01-30       Impact factor: 4.294

Review 3.  Nanoparticles: pharmacological and toxicological significance.

Authors:  C Medina; M J Santos-Martinez; A Radomski; O I Corrigan; M W Radomski
Journal:  Br J Pharmacol       Date:  2007-01-22       Impact factor: 8.739

4.  Synthesis and potential applications of silver-porous aluminium oxide nanocomposites as prospective antiseptics and bactericides.

Authors:  Marina Gorbunova; Larisa Lemkina; Irina Lebedeva; Dmitriy Kisel'kov; Larisa Chekanova
Journal:  J Mater Sci Mater Med       Date:  2017-01-31       Impact factor: 3.896

Review 5.  Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.

Authors:  Sibel Bozdağ Pehlivan
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

Review 6.  The effects of nanomaterials as endocrine disruptors.

Authors:  Ivo Iavicoli; Luca Fontana; Veruscka Leso; Antonio Bergamaschi
Journal:  Int J Mol Sci       Date:  2013-08-14       Impact factor: 5.923

7.  The Effects of Organic Solvents on the Physicochemical Properties of Human Serum Albumin Nanoparticles.

Authors:  Hossein Mohammad-Beigi; Seyed Abbas Shojaosadati; Dina Morshedi; Negar Mirzazadeh; Ayyoob Arpanaei
Journal:  Iran J Biotechnol       Date:  2016-03       Impact factor: 1.671

8.  Modulation of miRNA-155 alters manganese nanoparticle-induced inflammatory response.

Authors:  Matthew W Grogg; Laura K Braydich-Stolle; Elizabeth I Maurer-Gardner; Natasha T Hill; Suraj Sakaram; Madhavi P Kadakia; Saber M Hussain
Journal:  Toxicol Res (Camb)       Date:  2016-10-13       Impact factor: 3.524

Review 9.  Personalized nanomedicine advancements for stem cell tracking.

Authors:  Miroslaw Janowski; Jeff W M Bulte; Piotr Walczak
Journal:  Adv Drug Deliv Rev       Date:  2012-07-20       Impact factor: 15.470

10.  On the toxicity of therapeutically used nanoparticles: an overview.

Authors:  A El-Ansary; S Al-Daihan
Journal:  J Toxicol       Date:  2009-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.